Lv2
136 积分 2021-04-19 加入
Role of the CXCR6/CXCL16 axis in autoimmune diseases
2个月前
已完结
PRT3789 Is a First-in-Human SMARCA2-Selective Degrader That Induces Synthetic Lethality in SMARCA4 -Mutated Cancers
2个月前
已完结
Conformation-Dependent Complexation Interactions for a SMARCA2 PROTAC and Cyclodextrin
2个月前
已完结
Design, synthesis and pharmacological evaluation of new SMARCA2 degraders bearing a furo[3,2-c]pyridazine scaffold
2个月前
已完结
Discovery of ERD-3111 as a Potent and Orally Efficacious Estrogen Receptor PROTAC Degrader with Strong Antitumor Activity
2个月前
已完结
Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials
4个月前
已完结
Discovery of CFT8634, a Potent, Selective, and Orally Bioavailable Heterobifunctional Degrader of BRD9
5个月前
已完结
The Arylamine N-Acetyltransferases as Therapeutic Targets in Metabolic Diseases Associated with Mitochondrial Dysfunction
7个月前
已完结
Mining the CRBN target space redefines rules for molecular glue–induced neosubstrate recognition
8个月前
已完结
Base-editing mutagenesis maps alleles to tune human T cell functions
9个月前
已完结
皖公网安备34019202002308
